Summary of all studies containing PUBCHEM ID 23831
Project | Study | Study_title | Subject_type | Subject_species | Metabolite_name |
---|---|---|---|---|---|
PR001762 | ST002819 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) | Human | Homo sapiens | HEPES [Data] |
PR001941 | ST003365 | Intracellular and medium metabolomics for BT-474 breast cancer cells treated with a range of Fasnall and GSK2194069 concentrations for 24 h | Cultured cells | Homo sapiens | HEPES 107 [Data] |
PR001941 | ST003365 | Intracellular and medium metabolomics for BT-474 breast cancer cells treated with a range of Fasnall and GSK2194069 concentrations for 24 h | Cultured cells | Homo sapiens | HEPES 80 [Data] |
PR001941 | ST003367 | Intracellular and medium metabolomics for BT-474 cells treated with a range of C75 concentrations for 24 h | Cultured cells | Homo sapiens | HEPES 107 [Data] |
PR001941 | ST003367 | Intracellular and medium metabolomics for BT-474 cells treated with a range of C75 concentrations for 24 h | Cultured cells | Homo sapiens | HEPES 80 [Data] |
PR001941 | ST003411 | Intracellular and medium metabolomics for BT-474 cells treated with a range of C75 concentrations for 24 h (C75 MRM included) | Cultured cells | Homo sapiens | HEPES 107 [Data] |
PR001941 | ST003411 | Intracellular and medium metabolomics for BT-474 cells treated with a range of C75 concentrations for 24 h (C75 MRM included) | Cultured cells | Homo sapiens | HEPES 80 [Data] |
PR001941 | ST003412 | Intracellular and medium metabolomics for BT-474 cells treated with cerulenin, TVB-2640, and TVB-3166 for 24 h | Cultured cells | Homo sapiens | HEPES 107 [Data] |
PR001941 | ST003412 | Intracellular and medium metabolomics for BT-474 cells treated with cerulenin, TVB-2640, and TVB-3166 for 24 h | Cultured cells | Homo sapiens | HEPES 80 [Data] |
PR001941 | ST003427 | Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate | Cultured cells | Homo sapiens | HEPES 107 [Data] |
PR001941 | ST003427 | Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate | Cultured cells | Homo sapiens | HEPES 80 [Data] |
PR001941 | ST003433 | Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate, Fasnall, and GSK2194069 | Cultured cells | Homo sapiens | HEPES 107 [Data] |
PR001941 | ST003433 | Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate, Fasnall, and GSK2194069 | Cultured cells | Homo sapiens | HEPES 80 [Data] |
PR001941 | ST003429 | Intracellular and medium metabolomics of BT-474 cells treated with Fasnall that was manufactured by Enamine | Cultured cells | Homo sapiens | HEPES 107 [Data] |
PR001941 | ST003429 | Intracellular and medium metabolomics of BT-474 cells treated with Fasnall that was manufactured by Enamine | Cultured cells | Homo sapiens | HEPES 80 [Data] |
PR001941 | ST003430 | Intracellular and medium metabolomics of BT-474 cells treated with GSK2194069 | Cultured cells | Homo sapiens | HEPES 107 [Data] |
PR001941 | ST003430 | Intracellular and medium metabolomics of BT-474 cells treated with GSK2194069 | Cultured cells | Homo sapiens | HEPES 80 [Data] |
PR001941 | ST003432 | Intracellular and medium metabolomics of BT-474 cells treated with LW6 | Cultured cells | Homo sapiens | HEPES 107 [Data] |
PR001941 | ST003432 | Intracellular and medium metabolomics of BT-474 cells treated with LW6 | Cultured cells | Homo sapiens | HEPES 80 [Data] |
PR001941 | ST003428 | Intracellular and medium metabolomics of BT-474 cells treated with rotenone | Cultured cells | Homo sapiens | HEPES 107 [Data] |
PR001941 | ST003428 | Intracellular and medium metabolomics of BT-474 cells treated with rotenone | Cultured cells | Homo sapiens | HEPES 80 [Data] |
PR001941 | ST003366 | Malate dehydrogenase (MDH) inhibition assay: Fasnall does not affect MDH activity in vitro | Synthetic sample | HEPES 107 [Data] | |
PR001941 | ST003366 | Malate dehydrogenase (MDH) inhibition assay: Fasnall does not affect MDH activity in vitro | Synthetic sample | HEPES 80 [Data] | |
PR001941 | ST003431 | Metabolomics analysis of breast cancer cell lines treated with dimethylmalonate (DMM), GSK2194069, and their combination. | Cultured cells | Homo sapiens | HEPES 107 [Data] |
PR001941 | ST003431 | Metabolomics analysis of breast cancer cell lines treated with dimethylmalonate (DMM), GSK2194069, and their combination. | Cultured cells | Homo sapiens | HEPES 80 [Data] |
PR001941 | ST003435 | Metabolomics analysis of zebrafish embryos treated with rotenone, Fasnall, TVB-2640, and GSK2194069 | Fish | Danio rerio | HEPES 107 [Data] |
PR001941 | ST003435 | Metabolomics analysis of zebrafish embryos treated with rotenone, Fasnall, TVB-2640, and GSK2194069 | Fish | Danio rerio | HEPES 80 [Data] |
PR001488 | ST002322 | Metabolomics study comparing SCAP KO and WT B cells | Cultured cells | Mus musculus | HEPES [Data] |
PR001941 | ST003436 | Pharmacokinetics of Fasnall in NSG mice | Mammal | Mus musculus | HEPES 107 [Data] |
PR001941 | ST003436 | Pharmacokinetics of Fasnall in NSG mice | Mammal | Mus musculus | HEPES 80 [Data] |
PR000840 | ST001253 | Phenotyping Mouse blood metabolites in day and night in type 2 diabetes | Mammal | Mus musculus | HEPES [Data] |
PR001941 | ST003434 | Plasma concentrations of Fasnall in mice after a bolus of 10 mg/kg administered intraperitoneally. | Mammal | Mus musculus | HEPES 107 [Data] |
PR001941 | ST003434 | Plasma concentrations of Fasnall in mice after a bolus of 10 mg/kg administered intraperitoneally. | Mammal | Mus musculus | HEPES 80 [Data] |
PR001809 | ST002909 | Plasma metabolomics reveals distinct biological and diagnostic signatures for melioidosis | Human | Homo sapiens | HEPES [Data] |
PR001756 | ST002809 | Role of cilia in mitochondrial function | Mammal | Mus musculus;Canis lupus familiaris | HEPES [Data] |